Position in IDXX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,632
-$6,358 QoQ
Shares Held
5
-68.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,244
of 1,286 holders
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $400,845 across 10 Diagnostics & Research names. IDXX ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
1,141 | $171,184 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
185 | $92,751 | |
| 3 | A |
Agilent Technologies, Inc.
|
608 | $80,760 | |
| 4 | DHR |
Danaher Corp /De/
|
109 | $20,762 | |
| 5 | WAT |
Waters Corp /De/
|
35 | $13,126 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
23 | $12,180 | |
| 7 | DGX |
Quest Diagnostics Inc
|
26 | $5,510 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
This page
|
5 | $2,632 |
All Filings in IDXX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,632 | 5 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $8,990 | 16 | Shares | Sole | 2026-04-23 | |
| 2023-06-30 | $3,515 | 7 | Shares | Sole | 2023-08-03 | |
| 2021-12-31 | $5,267 | 8 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $31,095 | 50 | Shares | Sole | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||